---
title: Antiplatelets
author: J. Austin Straley, DO
layout: post
chapter: 9
section: 01
lesson: 14
date: 2023-03-30
---

- A) COX Inhibitors
  - Aspirin
- B) PDE Inhibitors
  - Cyclic AMP Interference
  - Dipyridamol (Persantine)
- C) PARI
  - Thrombin Receptor Interference
  - Vorapaxar (Zontivity)
- D) P2Y12
  - ADP Binding Inhibitors
  - Clopidogrel (Plavix)
    - Thienopyridine (IR)
  - Prasugrel (Effient)
    - Thienopyridine (IR)
  - Ticagrelor (Brilinta)
    - Nucleotide/side analog (R)
    - SE: Dyspnea MC
  - Ticlopidine (Ticlid)
    - Thienopyridine (IR)
- E) GIIb/IIIa Receptor Inhibitors
  - Eptifibutide (Integrilin)
  - Abciximab (Repro)
    - Monoclonal antibody
  - Tirofiban (Aggrastat)
- F) PDE3 Inhibitors
  - Cilostazole (Pletal)
    - Only indicated in symptomatic claudication
    - CI: HF

- Reye Syndrome
  - Use of aspirin after a URI
  - Symptoms
    - Acute encephalopathy w/hepatic dysfunction occurring days after recovery
    - Heavy vomiting, delirium, fatty liver, seizures, coma
  - Liver failure with elevated AST, ALT
  - Increased PT, elevated ammonia, and hypoglycemia
  - +/- Renal and heart failure, Increased ICP